Interview: NCCIH Director Josephine Briggs On The Science Supporting More Self-Care
This article was originally published in The Tan Sheet
Executive Summary
In an interview with “The Tan Sheet,” Briggs discusses topics including the lack of data on drug-supplement interactions and NCCIH’s interest in funding research on standards for assessing the clinical importance of those interactions.
You may also be interested in...
NCCIH Director Briggs Leaving: Health And Wellness Industry News
NCCIH Director Josephine Briggs will depart the center after nine years, with deputy director David Shurtleff serving as acting director; the 10th Circuit will not rehear MusclePharm's complaint against insurer; blood sugar supplement firm receives FDA warning letter; more news in brief.
NCCAM Director Aim For “Strong Portfolio” Of Studies Despite Funding Limits
National Center for Complementary and Alternative Medicines Director Josephine Briggs started in the post at a time when the center is expected to operate with no increase in federal funding, she says
Can Organovo Leverage Its Solid Phase II Data In MASH?
Cash-limited Organovo has an FXR agonist showing competitive efficacy and tolerability in MASH, but may need a partner to move forward in that disease as it may be prioritizing its IBD program.